Clin2
NCT06456736Possibly a fitNot yet recruiting

Autoimmune encephalitis in ICU: what predicts outcomes?

Autoimmune Encephalitis

Part of Brain & nervous system, Immune system & allergy clinical trials.

This study looks at adults with autoimmune encephalitis who needed care in the intensive care unit (ICU). It aims to find patterns and markers that help predict how patients will do.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
15 years and older
Study type
Observational

Who can take part

  • You must be diagnosed with autoimmune encephalitis (AE) according to 2022 guidelines.
  • You must be 15 years old or older.
  • You must have stayed in an adult ICU during your illness.
  • Your ICU stay must have been longer than 24 hours.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06760091Not yet recruiting
Autoimmune encephalitis study

This study is for people with autoimmune encephalitis, a condition where the immune system attacks the brain. It aims to collect information about this disease to learn more about it and how to treat it.

Beijing
NCT06584045Recruiting
Testing a bile-based treatment for adult encephalitis

This study tests a natural bile-derived medicine (Calcus Bovis Sativus) to see if it can help adults with new or recent brain inflammation (encephalitis). It focuses on people whose encephalitis is caused by the immune system or a virus, and who have not fully recovered.

Wuhan, Hubei
NCT07477015Recruiting
Study to find new antibodies in autoimmune encephalitis

This research study looks for new markers in the blood of people with autoimmune encephalitis (a condition where the immune system attacks the brain). It aims to better understand what causes the disease and find new ways to diagnose it.

Rome, RM
NCT06173076Recruiting
Study of outcomes in anti-LGI1 brain inflammation

This study follows people newly diagnosed with anti-LGI1 encephalitis (a brain inflammation) to see how well they do over time. It aims to learn more about the condition and improve care.

Hangzhou, Zhejiang
NCT07131683Not yet recruiting· Phase 1/Phase 2
Nasal stem cell exosomes for autoimmune encephalitis

This study tests whether an experimental treatment using tiny particles from stem cells (called exosomes) given through the nose can help people with autoimmune encephalitis. It is for adults who were recently diagnosed and have specific antibodies.

NCT06079294Recruiting
Autoimmune encephalitis and brain glucose metabolism

This study looks at how autoimmune encephalitis affects brain metabolism using a special PET scan. It aims to better understand the condition in people who were recently diagnosed.

Paris

Hear when a new Autoimmune Encephalitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.